Kezar Enterprise Value Over E B I T D A from 2010 to 2024

KZR Stock  USD 7.41  0.06  0.80%   
Kezar Life Enterprise Value Over EBITDA yearly trend continues to be relatively stable with very little volatility. Enterprise Value Over EBITDA is likely to drop to -7.09. During the period from 2010 to 2024, Kezar Life Enterprise Value Over EBITDA destribution of quarterly values had r-value of  0.85 from its regression line and median of (260.46). View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(6.76)
Current Value
(7.09)
Quarterly Volatility
109.90845774
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Kezar Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kezar Life's main balance sheet or income statement drivers, such as Net Interest Income of 9.5 M, Interest Income of 11.1 M or Depreciation And Amortization of 1 M, as well as many indicators such as Price To Sales Ratio of 78.52, Dividend Yield of 0.0 or PTB Ratio of 3.85. Kezar financial statements analysis is a perfect complement when working with Kezar Life Valuation or Volatility modules.
  
Check out the analysis of Kezar Life Correlation against competitors.

Latest Kezar Life's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Kezar Life Sciences over the last few years. It is Kezar Life's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kezar Life's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

Kezar Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean(168.69)
Coefficient Of Variation(65.15)
Mean Deviation99.28
Median(260.46)
Standard Deviation109.91
Sample Variance12,080
Range264
R-Value0.85
Mean Square Error3,568
R-Squared0.73
Significance0.000055
Slope20.94
Total Sum of Squares169,118

Kezar Enterprise Value Over E B I T D A History

2024 -7.09
2023 -6.76
2022 -71.45
2021 -165.64
2020 -56.67
2019 -21.98
2018 -106.7

About Kezar Life Financial Statements

Kezar Life shareholders use historical fundamental indicators, such as Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Kezar Life investors may analyze each financial statement separately, they are all interrelated. The changes in Kezar Life's assets and liabilities, for example, are also reflected in the revenues and expenses on on Kezar Life's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA(6.76)(7.09)

Pair Trading with Kezar Life

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kezar Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kezar Life will appreciate offsetting losses from the drop in the long position's value.

Moving against Kezar Stock

  0.81VCNX VaccinexPairCorr
  0.54DRMA Dermata TherapeuticsPairCorr
  0.52VALN Valneva SE ADRPairCorr
  0.37ME 23Andme HoldingPairCorr
  0.34DRRX DurectPairCorr
The ability to find closely correlated positions to Kezar Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kezar Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kezar Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kezar Life Sciences to buy it.
The correlation of Kezar Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kezar Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kezar Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kezar Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Kezar Stock Analysis

When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.